• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Finint & Partners buys CVS Ferrari

  • Amedeo Goria
  • Amedeo Goria
  • 22 November 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Finint & Partners-managed investment vehicle Nord Est Investment Partners III (NEIP III) has wholly acquired Italian handling machinery business CVS Ferrari from US listed corporate Manitex International.

The all-equity transaction saw Finint acquire the targeted company via its NEIP III vehicle alongside Parma-based corporate BP Handling Technologies. According to a source familiar with the situation, the deal originated when BP and CVS started collaborating on a new product, an electric-diesel hybrid empty container handler.

As part of the partnership, CVS retained its product's exclusive distribution rights. When Manitex showed interest in divesting the asset following a business rationalisation programme, BP found in Finint the financial partner to support the acquisition and the merger between the two businesses.

CVS Ferrari

  • DEAL:

    Buyout

  • LOCATION:

    Roveleto

  • SECTOR:

    Industrial machinery

  • FOUNDED:

    1973

  • TURNOVER:

    €45m

Following the transaction, which is expected to close by the end of 2016, NEIP III will control a 60% stake in the merged group, while BP will own the remaining 40% stake.

According to a statement, the merged group will generate an aggregate turnover of €50m and employ a staff of 100. CVS's current CEO, Stefano Mercati, will continue to lead the business.

The deal marks the seventh investment for NEIP III, which held a final close on €75m in December 2011 and expects to be 70% invested by the end of 2016, the GP said in a statement.

The fund recently acquired a 75% stake in Italian bread producer Panificio San Franceso in June 2016 and divested Nuova Giungas, an isolation joints manufacturer, via a trade sale to CDP Equity's Valvitalia.

Company
Established in 1973 and headquartered in Roveleto, near Piacenza, CVS Ferrari produces container handling machinery for the industrial sector. Its products include tractors, straddle carriers, forklift trucks, reach stackers and empty handlers.

In 2015, the company generated €45m in revenues, according to a source.

People
Finint & Partners – Nicola Bordignon (partner).
Gruppo Battioni Pagani – Federico Zanotti (CEO).
CVS Ferrari – Stefano Mercati (CEO).

Advisers
Equity – Studio Simonazzi (M&A); King & Wood Mallesons (legal); PwC (financial due diligence, tax); Studio Ceccarelli (commercial due diligence).
Vendor – Orrick (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Industrials
  • Southern Europe
  • Italy

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013